JENA, Germany, Feb. 26, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in the Leerink Partners Global Healthcare Conference. Details are as follows: Leerink Partners Global Healthcare ConferenceMarch 8 - 11, 2026 in Miami, FLFireside chat on March 9 at 9:20 AM ET InflaRx will also conduct one-on-one investor meetings on March 9th. A link to view the fireside ch ...

GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that it will report its fourth quarter 2025 financial results on Thursday, March 5, 2026. Altimmune management will host a conference call at 8:30 a.m. ET on March 5 to discuss the financial results and provide a business update. The conference call will be webcast live on Altimmune’s Investor Relations w ...

Rare earth element and niobium anomalies found in sediments and surrounding rocksVancouver, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Initial prospecting results and geological observations suggest that the broader area encompassing North American Niobium and Critical Minerals Corp.’s (CSE: NIOB) (OTCQB: NIOMF) (FSE: KS82.F) Bardy, Blanchette and Sabot projects in Québec may be comparable in style to the large rare-earth element (REE) deposits found in Greenland. As such, the Company has begun a t ...

Giant Containers to design and build critical infrastructure and community amenities for transformative urban state park spanning northern New JerseyCONROE, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- via IBN — Olenox Industries Inc. (NASDAQ: OLOX) (“Olenox Industries” or the “Company”) today announced that its subsidiary, Giant Containers, has been selected to provide design and construction services for critical infrastructure and amenities as part of the nearly one-mile Newark segment of New Jersey’s newest ...

HOLLISTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2025, before the market opens on March 12, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. Participants who would like to join the audio-only we ...

HAELO Phase 3 clinical data for lonvo-z in HAE expected by mid-2026; BLA submission in second half of 2026; anticipated U.S. launch in first half of 2027Process underway to reactivate global sites for MAGNITUDE-2 Phase 3 clinical trial of nex-z in ATTRv-PN; enrollment completion expected in second half of 2026FDA engagement ongoing to resolve clinical hold on MAGNITUDE Phase 3 clinical trial of nex-z in ATTR-CM Ended 2025 with approximately $605 million in cash, cash equivalents and marketable securities; e ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESTORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36 | OTCQB: JORFF) (“CLM” or the “Company”) announces today that it intends to complete a non-brokered private placement offering (the “Offering”) of securities of the Company for aggregate gross proceeds to the Company of up to $17,070,000, in a combination of: a) up to 31,250,000 units of the Company that will be issued ...

On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and with higher doses of WVE-007 (INHBE GalNAc-siRNA), while preserving muscle mass Planning underway to initiate Phase 2a multidose portion of WVE-007 INLIGHT clinical trial for obesity in individuals with higher BMI and comorbidities in 1H 2026, as well as additional trials of WVE-007 as an incretin add-on and as post-incretin maintenance in 2026 Advancing regulatory ...

Signed Purchase Orders for DFR-X Systems Advance the Development of Wrap’s Drone First Responder Interdiction PlatformMIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in Non-Lethal Response (“NLR”) and public safety technology, today announced an expansion of the scope of its manufacturing partnership with K-Form, Inc. (“Kform”), intended to accelerate development and production of Wrap’s drone-based non-lethal systems, MERLIN-1, incl ...

Two decades of global service excellence underscore Colliers’ commitment to client successTORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Colliers (NASDAQ, TSX: CIGI), a leading diversified professional services and investment management company, has been named to the 2026 Global 100 list produced by IAOP® in the Leader category for large, established global firms. This marks the 20th consecutive year that Colliers has been recognized for global service excellence. IAOP’s annual list recognizes the world’s top o ...